What to know about Medicare drug price negotiation

In this episode, Todd Askew, AMA senior vice president of Advocacy, presents what physicians need to know about Medicare drug price negotiations for seniors in the US health care system. The topic has ebbed and flowed for many years and has recently been debated again in Congress. Allowing CMS to negotiate drug prices on behalf of its beneficiaries and private plan enrollees would help reduce out-of-pocket spending. Listen in to learn more.     ⭐⭐⭐⭐⭐ 🩺 The AMA is your powerful ally, focused on addressing the issues important to you, so you can focus on what matters most — patients. We will meet this challenge together. Join us: https://ama-assn.co/JoinRenew  🥼 Go to https://ama-assn.co/FightingForDocs to learn more about our AMA advocacy priorities, including:  ▹ Reforming Medicare payment  ▹ Fighting scope creep  ▹ Fixing prior authorization  ▹ Reducing physician burnout  ▹ Making technology work for physicians  📺 Subscribe to @americanmedicalassociation on YouTube: https://ama-assn.co/youTube  📧 Sign up for #MorningRounds and free daily newsletters from the AMA: https://ama-assn.co/Newsletters  💬 Follow #AMA on social media: https://ama-assn.co/Social